Public Dashboard: Morningstar 4 Bargains (9/11/2020)
These undervalued wide-moat stocks earn low uncertainty ratings. -- Susan Dziubinski
04/30/2025 | ||||||||||||
Company | Symbol | Shares | Price | Value | % of Total | Growth | Proj P/E | Proj Yield | Fin Str | EPS Stab | Qlty | PAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Averages | $549.41 | 3.3% | 14.2 | 2.6% | 69% | 62 | 67.5 | 7.7% | ||||
Coca-Cola | KO | 1.96 | $72.35 | $141.70 | 25.8% | 4.5% | 21.8 | 3.0% | 98% | 99 | 95 | 7.5% |
Novartis | NVS | 1.11 | $112.63 | $125.31 | 22.8% | 4.9% | 17.7 | 3.1% | 91% | 62 | 86 | 8.3% |
Pfizer | PFE | 2.77 | $23.79 | $65.96 | 12.0% | 2.8% | 10.0 | 4.2% | 91% | 58 | 81 | 13.5% |
Roche Holdings* | RHHBY | 2.21 | $40.71 | $89.99 | 16.4% | 4.4% | 20.1 | 3.5% | 75% | 94 | 84 | 14.1% |
Vanguard Total Stock Market | VTSMX | 1.22 | $104.05 | $126.46 | 23.0% | 0.0% | 0.0 | 0.0% | 0% | 0 | 0 | -0.1% |